Greenland Mines (GRML) Stock Analysis

What Greenland Mines does

Greenland Mines Ltd operates across two segments: natural resources and cell and gene therapy. Its resources arm is focused on exploring for palladium, gold, and platinum, centered on the exploration and development of the Skaergaard project in Southeast Greenland. On the therapeutics side, the company is developing KLTO-202, a gene therapy targeting the treatment and prevention of amyotrophic lateral sclerosis (ALS), and KLTO-101, aimed at treating or preventing Alzheimer's disease, alongside therapies for Parkinson's and other age-related conditions. Previously known as Klotho Neurosciences, Inc., the company adopted its current name in March 2026. It is headquartered in Charlotte, North Carolina.

Key metrics

ETFs linked to GRML

Broad-market and Basic Materials sector ETFs an investor holding Greenland Mines is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how GRML fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Frequently asked questions

What is the ticker symbol for Greenland Mines?

Greenland Mines trades under the ticker GRML on NASDAQ.

Which exchange is GRML listed on?

GRML is listed on NASDAQ.

What sector does Greenland Mines operate in?

Greenland Mines is classified in the Basic Materials sector (Other Precious Metals industry).

How can PortView help analyze GRML in a portfolio?

PortView shows GRML's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.